Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial

Jens Lundgren; Abdel Babiker; Fred Gordin; Sean Emery; Gerd Fätkenheuer; Jean-Michel Molina; Robin Wood; James D Neaton; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members)

doi:10.1111/hiv.12227

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Jens Lundgren, Abdel Babiker, Fred Gordin, Sean Emery, Gerd Fätkenheuer, Jean-Michel Molina, Robin Wood, James D Neaton, INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members)

Department of Infectious Diseases

27 Citations (Scopus)

Original language	English
Journal	HIV Medicine
Volume	16 Suppl 1
Pages (from-to)	1-9
Number of pages	9
ISSN	1464-2662
DOIs	https://doi.org/10.1111/hiv.12227
Publication status	Published - Apr 2015

Access to Document

10.1111/hiv.12227

Cite this

Lundgren, J., Babiker, A., Gordin, F., Emery, S., Fätkenheuer, G., Molina, J.-M., Wood, R., Neaton, J. D., & INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members) (2015). Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine, 16 Suppl 1, 1-9. https://doi.org/10.1111/hiv.12227

Lundgren, J, Babiker, A, Gordin, F, Emery, S, Fätkenheuer, G, Molina, J-M, Wood, R, Neaton, JD & INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members) 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, vol. 16 Suppl 1, pp. 1-9. https://doi.org/10.1111/hiv.12227

@article{ed1cf89fd1b945e985c900a6fbb7b170,

title = "Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial",

author = "Jens Lundgren and Abdel Babiker and Fred Gordin and Sean Emery and Gerd F{\"a}tkenheuer and Jean-Michel Molina and Robin Wood and Neaton, \{James D\} and \{INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members)\} and Mathiesen, \{Lars Reinhardt\}",

year = "2015",

month = apr,

doi = "10.1111/hiv.12227",

language = "English",

volume = "16 Suppl 1",

pages = "1--9",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Why START?

T2 - Reflections that led to the conduct of this large long-term strategic HIV trial

AU - Lundgren, Jens

AU - Babiker, Abdel

AU - Gordin, Fred

AU - Emery, Sean

AU - Fätkenheuer, Gerd

AU - Molina, Jean-Michel

AU - Wood, Robin

AU - Neaton, James D

AU - INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members)

A2 - Mathiesen, Lars Reinhardt

PY - 2015/4

Y1 - 2015/4

UR - https://www.scopus.com/pages/publications/84923323284

U2 - 10.1111/hiv.12227

DO - 10.1111/hiv.12227

M3 - Journal article

C2 - 25711317

SN - 1464-2662

VL - 16 Suppl 1

SP - 1

EP - 9

JO - HIV Medicine

JF - HIV Medicine

ER -

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Access to Document

Other files and links

Cite this